Navigation Links
Lilly Reports First-Quarter 2011 Results
Date:4/18/2011

Lilly)

Cymbalta® (duloxetine hydrochloride, Lilly)

Effient® (prasugrel, Lilly)

Erbitux® (cetuximab, ImClone Systems, Lilly)

Evista® (raloxifene hydrochloride, Lilly)

Forteo® (teriparatide of recombinant DNA origin injection, Lilly)

Gemzar® (gemcitabine hydrochloride, Lilly)

Humalog® (insulin lispro injection of recombinant DNA origin, Lilly)

Humulin® (human insulin of recombinant DNA origin, Lilly)

Strattera® (atomoxetine hydrochloride, Lilly)

Trifexis™ (spinosad + milbemycin oxime, Lilly)

Zyprexa® (olanzapine, Lilly)Eli Lilly and Company Employment InformationMarch 31, 2011

December 31, 2010Worldwide Employees38,16538,350Eli Lilly and CompanyOperating Results  (Unaudited) – REPORTED(Dollars in millions, except per share data)Three Months EndedMarch 312011  

2010

% Chg.Total revenue

$

5,839.2

$

5,485.5

6%Cost of sales1,180.11,122.5

5%Research and development1,124.01,039.1

8%Marketing, selling and administrative1,785.71,614.4

11%Acquired in-process research and

  development388.050.0

NMAsset impairments, restructuring

  and other special charges76.326.2

NMOperating income 1,285.11,633.3

(21)%Net interest income (expense)(30.3)(37.0)Net other income (expense)19.1111.5Other income  (expense)(11.2)74.5

NMIncome before income taxes1,273.91,707.8

(25)%Income taxes 218.0459.7

(53)%Net income

$

1,055.9

$

1,248.1

(15)%Earnings per share – basic

$

0.95

$

1.13

(16)%Earnings per share – diluted

$

0.95

$

1.13

(16)%Dividends paid per share

$

0.49

$

0.49

NMWeighted-average sharesoutstanding (thousands) – basic1,112,0031,103,380We
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)...  Array BioPharma Inc. (NASDAQ: ARRY ) ... full year of its fiscal year ended June ... of Array, noted, "Binimetinib and encorafenib, two innovative ... for regulatory submissions in 2016. Additional data shared ... colorectal cancer further validate the value of these ...
(Date:8/3/2015)... YORK , Aug. 3, 2015 Immune ... Immune,s CEO, Dr. Daniel Teper , will present ... DATE:  Thursday, August 6, 2015 TIME:   11:30AM EDT LINK:    ... a live, interactive online event where investors are invited ... in the presentation hall as well as the association,s ...
(Date:8/3/2015)... Aug. 3, 2015  Sorrento Therapeutics, Inc. (NASDAQ: ... into an exclusive licensing agreement to develop and commercialize ... Mabtech Limited, a holding company for premier antibody development ... Under the terms of the agreement, ... (mAbs) for the North American, European and Japanese market. ...
Breaking Medicine Technology:Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 2Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 4
... ROCKVILLE, Md., Oct. 5 Sequella, Inc., a clinical-stage ... life-threatening infectious diseases, today announced that it received a ... and Reinvestment Act (ARRA) of 2009. The ARRA funds, ... Diseases (NIAID) of the National Institute of Health (NIH), ...
... First Recipient of adjunctive screening system , NEWPORT BEACH, ... initiated a program of donating VELscope® Oral Cancer Screening ... helping communities with, underserved populations. The first recipient ... Center, commonly known as Native Heath, in Phoenix, Arizona, ...
Cached Medicine Technology:Sequella Receives American Recovery and Reinvestment Funding Through the NIH 2Oral Cancer Foundation to Donate Screening Devices to Free Clinics 2Oral Cancer Foundation to Donate Screening Devices to Free Clinics 3Oral Cancer Foundation to Donate Screening Devices to Free Clinics 4
(Date:8/3/2015)... ... August 03, 2015 , ... Representatives with Health ... on its website. , “Our ‘Ask a Nutritionist’ feature on our website is a ... healthily,” said Liza Brisk, nutritionist and spokeswoman for Health Food Grocers. , Health Food ...
(Date:8/3/2015)... ... August 03, 2015 , ... The Workgroup for Electronic Data ... IT to create efficiencies in healthcare information exchange, announced the release of its findings ... and Human Services (HHS) Secretary, WEDI shared survey results and recommendations ...
(Date:8/3/2015)... ... ... They know every second counts. And when it comes to stroke, the ... best care in the nation. For the past two months, the stroke team led ... time in the country. During the months of June and July, it took the ...
(Date:8/3/2015)... ... 03, 2015 , ... BESLER Consulting today announced the firm ... The MarketingProfs Bright Bulb B2B Awards celebrate the best marketing, communications, and creative ... of their Readmissions Analytics product was selected as one of four finalists in ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novation, the nation’s largest ... pharmacogenetic lab testing and precision medicine solutions that can help pharmacists and other ... more than 8.6 million adverse drug events are reported in the U.S. ...
Breaking Medicine News(10 mins):Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 2Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 3Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 2Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 3Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 4Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3
... threeat to the globe as 95% of the AIDS ... General Assembly Special Session on HIV/AIDS, physicians demanded to ... would cater the AIDS victims in developing countries. ... (commonly known as Medicines Sans Frontieres, or MSF), MSF ...
... herbal product ginseng root has a number of psychological ... boosting mood performance. But researchers have found no psychological ... PhD, associate professor and co-director of the sport and ... Corvallis, Oregon and his colleague, Hermann Engles, PhD, conducted ...
... inherited disease of the nervous system due to the ... such as involuntary movements and balance problems and later ... well. ,All these days, until now, it was ... form of the protein 'huntingtin' which is responsible for ...
... bacteria known as E. coli 0157:H7 causes some of ... adults. Infections with this organism are often caused by ... to treat children with E. coli bacterial infection increases ... ,"Our data suggests that antibiotics are not only ...
... go in for strategic alliances among themselves to ... and precluding cut-throat competition which would be detrimental ... the Commerce Secretary, Mr. Prabir Sengupta, at the ... Pharmaceuticals and Cosmetics Export Promotion Council here on ...
... its true , this salient disclosure revealed its truth when ... Dr. Fernando D. Martinez ,According to Dr.Fernando D.Martinez and collegues ... between 6 and 11 years of age have a sevenfold ... any such associated risk of asthma even if they are ...
Cached Medicine News:Health News:Pharma cos must forge Strategic alliances 2
... 1575 immunowash microplate washer ... needle position to perform ... maximize wash efficiency. This ... choice of wash that ...
... LMW Automated Microplate ... choice for any laboratory. ... sensor allows a precise ... residual volume, digitally controlled ...
... ELx50 is a fast and versatile automated strip ... manifold. It is a self contained and programmable ... fluidic delivery from the gentle dripping of a ... pressure delivery systems. ELx50/12V processes 1 x 12 ...
... The Microplate washer MP-1200 is ... microplate washing system. Its internal micropumps ... and to discharge from all types ... microplate to be washed in rows ...
Medicine Products: